The store will not work correctly when cookies are disabled.
6-(4-Methoxyphenyl)-2-phenylimidazo[1,2-a]pyridine
ID: ALA4437559
PubChem CID: 155512521
Max Phase: Preclinical
Molecular Formula: C20H16N2O
Molecular Weight: 300.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2ccc3nc(-c4ccccc4)cn3c2)cc1
Standard InChI: InChI=1S/C20H16N2O/c1-23-18-10-7-15(8-11-18)17-9-12-20-21-19(14-22(20)13-17)16-5-3-2-4-6-16/h2-14H,1H3
Standard InChI Key: HKBLHFNEUUWGTB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
2.1778 -7.6890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1766 -8.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8847 -8.9175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5943 -8.5081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5915 -7.6854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8829 -7.2801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2992 -8.9148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2991 -9.7331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0066 -10.1405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0027 -8.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7107 -8.9093 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7177 -9.7278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4984 -9.9741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9739 -9.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4870 -8.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7897 -9.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2038 -10.0048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0202 -9.9982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4235 -9.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0044 -8.5800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1894 -8.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4700 -7.2806 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4698 -6.4634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.36 | Molecular Weight (Monoisotopic): 300.1263 | AlogP: 4.68 | #Rotatable Bonds: 3 |
Polar Surface Area: 26.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.42 | CX LogP: 4.28 | CX LogD: 4.28 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.55 | Np Likeness Score: -1.32 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |